查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1717269

2025年病患风险分层全球市场报告

Patient Risk Stratification Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年患者风险分层市场规模将呈指数级增长。到 2029 年，这一数字将成长至 83 亿美元，年复合成长率（CAGR）为 31.0%。展望未来，预测期内的成长预计将受到中阶的扩大和医疗保险覆盖率的提高、慢性病患病率的上升、预测分析的日益普及、对健康社会决定因素 (SDOH) 的更多关注以及技术的广泛使用的推动。预测期内的关键趋势包括分析、人工智慧 (AI)、机器学习、医疗保健创新、穿戴式技术和远端监控方面的进步。

慢性病负担的增加预计将推动患者风险分层市场的成长。慢性病是一种长期健康状况，通常持续三个月以上。慢性病的增加归因于多种因素，包括人口老化、不健康的生活方式、都市化、环境因素、医疗保健机会有限、经济差距和压力水平上升。病患风险分层可识别患有慢性病的不同风险等级的个体，从而实现个人化照护、早期疗育、更好的资源管理和改善健康结果。例如，美国国家生物技术资讯中心（NCBI）在2023年1月预测，患有至少一种慢性病的50岁及以上人群数量将增加99.5%，从2020年的7150万人增加至2050年的1.427亿人。此外，世界卫生组织（WHO）在2022年9月透露，慢性病占全球整体的74%，每年造成4,100万人死亡。心血管疾病造成 1,790 万人死亡，癌症造成 930 万人死亡，慢性呼吸道疾病造成 410 万人死亡，糖尿病造成 200 万人死亡。因此，慢性病盛行率的上升是患者风险分层市场的主要驱动力。

患者风险分层市场中的公司正在推进疾病筛检中的人工智慧 (AI) 等医疗保健技术，以透过提供更准确的风险评估和个人化治疗计划来改善早期发现、患者治疗结果并降低医疗保健成本。疾病筛检中的人工智慧采用先进的演算法和机器学习来分析医疗数据，透过快速处理大量数据集促进疾病的早期发现，并提高诊断的准确性。例如，2024年5月，加拿大医疗保健公司WELL Health Technologies Corporation与其投资组合公司HEALWELL AI推出了WELL AI决策支援（WAIDS）。该工具专注于罕见疾病和慢性病，如肾臟病、高血压和糖尿病，提供风险分层并帮助临床医生识别护理差距和可操作的数据。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 - 市场 - 宏观经济情境 宏观经济情境包括利率、通膨、地缘政治以及感染疾病和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球病患风险分层PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球病患风险分层市场：成长率分析
  • 全球病患风险分层市场表现：规模与成长，2019-2024 年
  • 全球病患风险分层市场预测：规模与成长，2024-2029 年，2034 年
  • 全球病患风险分层总目标市场（TAM）

第六章市场区隔

  • 全球病患风险分层市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 预测风险分层模型
  • 回顾性风险分层模型
  • 前瞻性风险分层模型
  • 同步风险分层模型
  • 全球病患风险分层市场组成、表现及预测（2019-2024、2024-2029、2034）
  • 软体
  • 服务
  • 全球病患风险分层市场（按交付模式、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 本地
  • 云端基础
  • 全球病患风险分层市场的应用、表现与预测，2019-2024 年、2024-2029 年、2034 年
  • 风险调整
  • 临床工作流程
  • 收益周期管理
  • 其他用途
  • 全球病患风险分层市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医疗保健提供者
  • 医疗保健付款人
  • 其他最终用户
  • 全球病患风险分层市场、预测风险分层模型细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 基于机器学习的预测模型
  • 统计预测模型
  • 基于人工智慧的预测模型
  • 全球病患风险分层市场、回顾性风险分层模型细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 历史风险模型
  • 资料探勘的回顾模型。
  • 全球病患风险分层市场，按类型、表现和预测的风险分层模型细分，2019-2024 年、2024-2029 年、2034 年
  • 基于纵向伫列的模型
  • 即时风险评估模型
  • 全球病患风险分层市场、同步风险分层模型细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 院内风险评估模型
  • 即时临床决策支援模型

第七章 区域和国家分析

  • 全球病患风险分层市场（按地区、绩效及预测）：2019-2024 年、2024-2029 年、2034 年
  • 全球病患风险分层市场（依国家、表现及预测）：2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 病患风险分层市场：竞争格局
  • 病患风险分层市场：公司简介
    • Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Sales Force Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Siemens Healthineers AG
  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Adobe Inc.
  • Persistent Systems
  • NextGen Healthcare Inc.
  • Health Catalyst
  • Freenome
  • Strive Health
  • Medeanalytics Inc.
  • American Academy of Family Physicians
  • Lightbeam Health Solutions
  • Graphnet Health Ltd.
  • Innova Medical Group Inc.
  • Equipo Health Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年病患风险分层市场：提供新机会的国家
  • 2029年病患风险分层市场：细分领域带来新机会
  • 2029年病患风险分层市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r33847

Patient risk stratification involves evaluating and classifying patients based on their likelihood of experiencing adverse health events. This process helps identify high-risk individuals for targeted interventions, optimize the use of resources, promote preventive care, improve care coordination, enhance patient outcomes, reduce costs, and aid in managing population health.

The primary types of patient risk stratification include predictive, retrospective, prospective, and concurrent models. Predictive risk stratification models analyze historical and current patient data to predict future health outcomes and identify those at high risk of developing particular conditions or complications. These models consist of software and services, with delivery options available both on-premise and via the cloud. Key applications include risk adjustment, clinical workflows, revenue cycle management, among others, and they are utilized by various end users, including healthcare providers, payers, and others.

The patient risk stratification market research report is one of a series of new reports from The Business Research Company that provides patient risk stratification market statistics, including patient risk stratification industry global market size, regional shares, competitors with a patient risk stratification market share, detailed patient risk stratification market segments, market trends and opportunities, and any further data you may need to thrive in the patient risk stratification industry. This patient risk stratification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The patient risk stratification market size has grown exponentially in recent years. It will grow from $2.15 billion in 2024 to $2.82 billion in 2025 at a compound annual growth rate (CAGR) of 31.3%. The growth during the historical period can be attributed to the growing adoption of digitization, increased health risks, an aging population, a rise in medical errors, and the widespread use of electronic health records (EHR).

The patient risk stratification market size is expected to see exponential growth in the next few years. It will grow to $8.30 billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. Looking ahead, growth during the forecast period is expected to be driven by the expanding middle class and health insurance coverage, the increasing prevalence of chronic diseases, the rising adoption of predictive analytics, a greater focus on social determinants of health (SDOH), and the broader use of technology. Key trends in the forecast period include advancements in analytics, artificial intelligence (AI), machine learning, healthcare technological innovations, wearable technology, and remote monitoring.

The increasing burden of chronic diseases is expected to drive the growth of the patient risk stratification market. Chronic diseases are long-term health conditions that typically last for three months or longer. The rise in chronic diseases can be attributed to several factors, including an aging population, unhealthy lifestyles, urbanization, environmental factors, limited access to healthcare, economic disparities, and elevated stress levels. Patient risk stratification helps identify individuals at varying risk levels for chronic diseases, enabling personalized care, early intervention, better resource management, and improved health outcomes. For example, in January 2023, the National Center for Biotechnology Information (NCBI) projected that the number of individuals aged 50 and older with at least one chronic illness will increase by 99.5%, from 71.5 million in 2020 to 142.7 million by 2050. Additionally, the World Health Organization (WHO) highlighted in September 2022 that chronic diseases are responsible for 74% of all deaths globally, equating to 41 million deaths annually. Cardiovascular diseases account for 17.9 million deaths, cancer causes 9.3 million, chronic respiratory diseases lead to 4.1 million deaths, and diabetes results in 2 million deaths. Consequently, the rising prevalence of chronic diseases is a major driver of the patient risk stratification market.

Companies in the patient risk stratification market are advancing healthcare technologies, such as artificial intelligence (AI) in disease screening, to improve early detection, patient outcomes, and reduce healthcare costs by providing more accurate risk assessments and personalized treatment plans. AI in disease screening employs sophisticated algorithms and machine learning to analyze medical data, facilitating early disease detection and improving diagnostic accuracy by quickly processing large datasets. For example, in May 2024, WELL Health Technologies Corporation, a Canadian healthcare company, alongside its investee company HEALWELL AI, launched WELL AI Decision Support (WAIDS). This tool focuses on rare diseases and chronic conditions such as kidney disease, hypertension, and diabetes, offering risk stratification and helping clinicians identify care gaps and actionable data at the point of care.

In December 2023, Healthcare Outcomes Performance Company (HOPCo), a US-based provider specializing in healthcare performance improvement solutions, acquired MyACTome, a US-based company that offers a smartphone platform for assessing fall risk and frailty. This acquisition is aimed at improving patient outcomes and enhancing healthcare efficiency, particularly in patient risk stratification.

Major players in the patient risk stratification market are Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation

North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in patient risk stratification report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the patient risk stratification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The patient risk stratification market includes revenues earned by entities by risk assessment and stratification services, telehealth services, medication management services, chronic disease risk assessment services, and genomic risk stratification services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Patient Risk Stratification Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on patient risk stratification market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for patient risk stratification ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The patient risk stratification market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Predictive Risk Stratification Model; Retrospective Risk Stratification Model; Prospective Risk Stratification Model; Concurrent Risk Stratification Model
  • 2) By Component: Software; Services
  • 3) By Delivery Model: On-Premise; Cloud-Based
  • 4) By Application: Risk Adjustment; Clinical Workflow; Revenue Cycle Management; Other Applications
  • 5) By End User: Healthcare Providers; Healthcare Payers; Other End Users
  • Subsegments:
  • 1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models; Statistical Predictive Models; AI-Powered Predictive Models
  • 2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models; Data Mining Retrospective Models
  • 3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models; Real-Time Risk Assessment Models
  • 4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models; Real-Time Clinical Decision Support Models
  • Companies Mentioned: Bristol-Myers Squibb; Thermo Fisher Scientific Inc.; Abbott Laboratories; Sales Force Inc.; Medtronic plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Patient Risk Stratification Market Characteristics

3. Patient Risk Stratification Market Trends And Strategies

4. Patient Risk Stratification Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Patient Risk Stratification Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Patient Risk Stratification PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Patient Risk Stratification Market Growth Rate Analysis
  • 5.4. Global Patient Risk Stratification Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Patient Risk Stratification Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Patient Risk Stratification Total Addressable Market (TAM)

6. Patient Risk Stratification Market Segmentation

  • 6.1. Global Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Risk Stratification Model
  • Retrospective Risk Stratification Model
  • Prospective Risk Stratification Model
  • Concurrent Risk Stratification Model
  • 6.2. Global Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Services
  • 6.3. Global Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premise
  • Cloud-Based
  • 6.4. Global Patient Risk Stratification Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Risk Adjustment
  • Clinical Workflow
  • Revenue Cycle Management
  • Other Applications
  • 6.5. Global Patient Risk Stratification Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Healthcare Providers
  • Healthcare Payers
  • Other End Users
  • 6.6. Global Patient Risk Stratification Market, Sub-Segmentation Of Predictive Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Machine Learning-Based Predictive Models
  • Statistical Predictive Models
  • AI-Powered Predictive Models
  • 6.7. Global Patient Risk Stratification Market, Sub-Segmentation Of Retrospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Historical Data-Based Risk Models
  • Data Mining Retrospective Models
  • 6.8. Global Patient Risk Stratification Market, Sub-Segmentation Of Prospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Longitudinal Cohort-Based Models
  • Real-Time Risk Assessment Models
  • 6.9. Global Patient Risk Stratification Market, Sub-Segmentation Of Concurrent Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In-Hospital Risk Assessment Models
  • Real-Time Clinical Decision Support Models

7. Patient Risk Stratification Market Regional And Country Analysis

  • 7.1. Global Patient Risk Stratification Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Patient Risk Stratification Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Patient Risk Stratification Market

  • 8.1. Asia-Pacific Patient Risk Stratification Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Patient Risk Stratification Market

  • 9.1. China Patient Risk Stratification Market Overview
  • 9.2. China Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Patient Risk Stratification Market

  • 10.1. India Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Patient Risk Stratification Market

  • 11.1. Japan Patient Risk Stratification Market Overview
  • 11.2. Japan Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Patient Risk Stratification Market

  • 12.1. Australia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Patient Risk Stratification Market

  • 13.1. Indonesia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Patient Risk Stratification Market

  • 14.1. South Korea Patient Risk Stratification Market Overview
  • 14.2. South Korea Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Patient Risk Stratification Market

  • 15.1. Western Europe Patient Risk Stratification Market Overview
  • 15.2. Western Europe Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Patient Risk Stratification Market

  • 16.1. UK Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Patient Risk Stratification Market

  • 17.1. Germany Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Patient Risk Stratification Market

  • 18.1. France Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Patient Risk Stratification Market

  • 19.1. Italy Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Patient Risk Stratification Market

  • 20.1. Spain Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Patient Risk Stratification Market

  • 21.1. Eastern Europe Patient Risk Stratification Market Overview
  • 21.2. Eastern Europe Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Patient Risk Stratification Market

  • 22.1. Russia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Patient Risk Stratification Market

  • 23.1. North America Patient Risk Stratification Market Overview
  • 23.2. North America Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Patient Risk Stratification Market

  • 24.1. USA Patient Risk Stratification Market Overview
  • 24.2. USA Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Patient Risk Stratification Market

  • 25.1. Canada Patient Risk Stratification Market Overview
  • 25.2. Canada Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Patient Risk Stratification Market

  • 26.1. South America Patient Risk Stratification Market Overview
  • 26.2. South America Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Patient Risk Stratification Market

  • 27.1. Brazil Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Patient Risk Stratification Market

  • 28.1. Middle East Patient Risk Stratification Market Overview
  • 28.2. Middle East Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Patient Risk Stratification Market

  • 29.1. Africa Patient Risk Stratification Market Overview
  • 29.2. Africa Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Patient Risk Stratification Market Competitive Landscape And Company Profiles

  • 30.1. Patient Risk Stratification Market Competitive Landscape
  • 30.2. Patient Risk Stratification Market Company Profiles
    • 30.2.1. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sales Force Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Patient Risk Stratification Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers AG
  • 31.2. Koninklijke Philips N.V.
  • 31.3. GE HealthCare Technologies Inc.
  • 31.4. Adobe Inc.
  • 31.5. Persistent Systems
  • 31.6. NextGen Healthcare Inc.
  • 31.7. Health Catalyst
  • 31.8. Freenome
  • 31.9. Strive Health
  • 31.10. Medeanalytics Inc.
  • 31.11. American Academy of Family Physicians
  • 31.12. Lightbeam Health Solutions
  • 31.13. Graphnet Health Ltd.
  • 31.14. Innova Medical Group Inc.
  • 31.15. Equipo Health Inc.

32. Global Patient Risk Stratification Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Patient Risk Stratification Market

34. Recent Developments In The Patient Risk Stratification Market

35. Patient Risk Stratification Market High Potential Countries, Segments and Strategies

  • 35.1 Patient Risk Stratification Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Patient Risk Stratification Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Patient Risk Stratification Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer